All Stories

  1. Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment

    Article • Patient Preference and Adherence, November 2019, Taylor & Francis

    Rolin Wade

  2. Demographic And Clinical Characteristics Of Patients Prescribed Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor Therapy And Patients Whose Current Lipid-Lowering Therapy Was Modified

    Article • Therapeutics and Clinical Risk Management, November 2019, Taylor & Francis

    Rolin Wade

  3. Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors

    Article • Vascular Health and Risk Management, December 2018, Dove Medical Press

    Rolin Wade

  4. Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients

    Article • Therapeutics and Clinical Risk Management, December 2018, Dove Medical Press

    Rolin Wade